SHRC orders 5L relief for medical negligence
SHRC member V Kannadasan passed the order on a complaint moved by the woman's mother, K Devamani, alleging medical negligence and inhumane treatment at the PHC, which led to the stillbirth of her daughter Subbulakshmi's baby.
According to the complaint, Subbulakshmi, who was eight months pregnant, experienced heavy bleeding and was admitted to the PHC on Apr 26, 2021. She contracted COVID-19 during treatment and experienced severe physical and mental distress.
You Can Also Check:
Chennai AQI
|
Weather in Chennai
|
Bank Holidays in Chennai
|
Public Holidays in Chennai
She alleged that there was a delay in transferring her to a higher medical facility as a health worker compelled the complainant to clean the blood-stained floor and bed before boarding the ambulance.
Opposing the plea, the PHC's medical officer, Dr K Varadaraj, and auxiliary nurse midwife (ANM) Prabavathi denied instructing the complainant to clean the blood stains. They also denied negligence and emphasised timely medical response and referral to a higher facility.
Recording the submissions, the commission found that delay in shifting the patient contributed to the death of the baby.
"It was established that a worker, Muthulakshmi, was responsible for instructing the complainant to clean the delivery area, which caused the delay. The worker was later dismissed from service on Nov 6, 2022," SHRC said.
The commission also noted the director of public health and preventive medicine failed to include critical documents, including statements from the victim, in the enquiry report submitted to the commission.
While dismissing the complaint against the medical officer and ANM on duty for lack of direct evidence, SHRC held govt liable and ordered the relief for violation of the fundamental right to timely medical care under Article 21 of Constitution.
SHRC also recommended that govt increase the number of doctors, nurses, and medical staff in PHCs, especially in rural areas, and improve ambulance services with a focus on maternal care.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
33 minutes ago
- Time of India
Major breakthrough in Dharmasthala mass burial case: What was found?
News • 2 Weeks ago Jagdeep Dhankhar has suddenly resigned as Vice President, effective immediately, citing health concerns – two years before his term was set to end. This shocking move, coming right after the Monsoon Session began, has sparked intense speculation. Was it truly health-related, or was there more to his abrupt exit? Known for his outspoken views and frequent clashes with the judiciary and opposition, Dhankhar's tenure was tumultuous. From questioning Supreme Court rulings to allowing a motion for Justice Yashwant Varma's removal (after wads of cash were found at his home), his actions often stirred controversy. Now, the focus shifts to who will be the next Vice President of India. Names like Rajya Sabha deputy chairman Harivansh Singh are in the running, but social media is abuzz with other possibilities, from Nitish Kumar to Shashi Tharoor. The Constitution mandates that the vacancy must be filled "as soon as possible."
Time of India
35 minutes ago
- Time of India
Pfizer stock soars as earnings smash expectations, and company raises outlook
PFE stock: Pfizer 's stock rose more than 2% in early trading Tuesday after the pharmaceutical giant reported stronger-than-expected earnings and raised its full-year profit forecast because of the cost-cutting efforts and solid sales of its Covid products and other key drugs, as per a CNBC report. Pfizer's Stock Soars After Raising Profit Forecast The company now expects adjusted earnings per share for 2025 to come in between $2.90 and $3.10, up from its previous guidance of $2.80 to $3, according to the report. Pfizer also maintained its 2025 revenue forecast of $61 billion to $64 billion, as reported by CNBC. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Pfizer CFO David Denton said, 'We raised our full-year 2025 Adjusted diluted EPS guidance, demonstrating confidence in our ability to execute against our strategic priorities and deliver strong results for shareholders,' as quoted in the CNBC report. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 20 Pieces of Clothing Older Women should Avoid Learn More ALSO READ: Plastic Treaty 2025: Will world leaders finally address the $1.5 trillion health crisis in Geneva? How Pfizer Is Handling Political Pressure on Drug Prices The firm's upbeat outlook comes despite the challenges posed by US political pressure to lower drug prices, including tariffs and potential pricing reforms advocated by US president Donald Trump, as per the CNBC report. The company factored in these headwinds, along with a one-time $1.35 billion charge related to a licensing deal for its cancer treatment outside China, which will hit its third-quarter results, according to the report. Live Events Pfizer's Q2 Results Surprise Wall Street in a Big Way Investors were encouraged by Pfizer's second-quarter performance, which blew past Wall Street's expectations, as per the CNBC report. Adjusted earnings per share came in at 78 cents, which was well above the 58 cents analysts predicted, as reported by CNBC. Revenue also surged 10% year-over-year to $14.65 billion, according to the CNBC report. ALSO READ: As the July jobs report paints a grim picture, 114 companies plan layoffs in August - is yours on the list? Pfizer's Covid Products Lead Revenue Growth Behind the growth were Pfizer's Covid products, including its Comirnaty vaccine, which saw a 96% revenue increase from last year because of a larger market share and more international contracts, as per the CNBC report. The company's antiviral pill Paxlovid also posted strong sales, which rose 70% from the prior year despite fewer Covid infections worldwide, according to the CNBC report. Other drugs like Vyndaqel, used to treat heart muscle disease, as well as bladder cancer treatment Padcev and blood thinner Eliquis, contributed to the positive sales momentum, as per the report. However, the company faced headwinds from its breast cancer drug Ibrance, which saw lower US prices due to Medicare reforms and generic competition, according to the CNBC report. Pfizer's Cost-Cutting Plans to Boost Profits The second quarter results come after the firm in April increased its cost-cutting efforts, which aim to help the pharmaceutical firm recover from the rapid decline of its Covid business and stock price over the past few years, as per the report. Along with the added cuts announced in April, the company now expects to deliver around $7.7 billion in savings by the end of 2027 from two separate cost-cutting program, as reported by CNBC. FAQs What helped Pfizer's revenue grow this quarter? Mostly its Covid vaccine and antiviral pill, along with strong sales from other drugs like heart and cancer treatments, as per the CNBC report. What's Pfizer doing to cut costs? They've ramped up cost-cutting programs and expect to save about $7.7 billion by the end of 2027, as per the CNBC report.
News18
35 minutes ago
- News18
2 Dead, 58 Infected In Legionnaires' Disease Outbreak In New York City: What Is It?
Legionnaires' disease outbreak in Harlem results in 2 deaths and 58 cases. Health officials advise those with flu-like symptoms to seek urgent medical care. A cluster of Legionnaires' disease in the Harlem area of New York City left two people dead and at least 58 diagnosed, city health officials confirmed. The outbreak, first reported late last week with 22 cases and one death, more than doubled in size in just a few days. The New York City Health Department urged anyone in the affected area experiencing flu-like symptoms- especially older adults and those with pre-existing health conditions- to seek medical attention without delay. Acting Health Commissioner Dr. Michelle Morse said, as per ABC News, 'Legionnaires' disease can be effectively treated if diagnosed early. But people over 50, smokers, and those with chronic lung conditions should be especially cautious." What Is Legionnaires' Disease? Legionnaires' disease is a severe form of pneumonia, caused by Legionella bacteria. Its symptoms closely resemble those of the flu or Covid-19 and include a persistent cough, fever and chills, muscle aches and shortness of breath. If left untreated, the disease can become life-threatening, particularly for individuals with weakened immune systems. Unlike respiratory illnesses such as influenza or coronavirus, Legionnaires' disease is not spread from person to person. It can, however, be successfully treated with antibiotics when caught early, making early detection and diagnosis essential. The Legionella bacteria thrive in warm water environments and are commonly found in places like the cooling towers of large air-conditioning systems, hot tubs and whirlpool spas, humidifiers, hot water tanks and complex plumbing systems. These settings can inadvertently provide ideal conditions for the bacteria to grow and multiply. In Harlem, 11 cooling towers tested positive for Legionella pneumophila, the specific strain responsible for the outbreak, according to the Health Department. People typically become infected by inhaling water vapor or mist contaminated with the bacteria- for example, from air conditioning systems, public fountains or rising steam. Officials clarified that the disease cannot be spread through drinking water or passed from one person to another. Where Did The Name 'Legionnaires'' Come From? The disease gets its name from a 1976 outbreak during an American Legion convention in Philadelphia which left 34 people dead and more than 200 ill. Investigators eventually traced the cause to the hotel's cooling system which had released contaminated water droplets into the air. The event was the first major recognition of the disease and led to the discovery of the Legionella bacterium. Get breaking news, in-depth analysis, and expert perspectives on everything from geopolitics to diplomacy and global trends. Stay informed with the latest world news only on News18. Download the News18 App to stay updated! view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
